299 related articles for article (PubMed ID: 30450291)
21. Malignant pleural mesothelioma.
Chen SE; Pace MB
Am J Health Syst Pharm; 2012 Mar; 69(5):377-85. PubMed ID: 22345416
[TBL] [Abstract][Full Text] [Related]
22. The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice.
Li Q; Yano S; Ogino H; Wang W; Uehara H; Nishioka Y; Sone S
Clin Cancer Res; 2007 Oct; 13(19):5918-25. PubMed ID: 17908988
[TBL] [Abstract][Full Text] [Related]
23. SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
Iwahori K; Serada S; Fujimoto M; Ripley B; Nomura S; Mizuguchi H; Shimada K; Takahashi T; Kawase I; Kishimoto T; Naka T
Int J Cancer; 2013 Jan; 132(2):459-71. PubMed ID: 22532243
[TBL] [Abstract][Full Text] [Related]
24. BRCA-associated protein 1 (BAP1) and miR-31 combination predicts outcomes in epithelioid malignant pleural mesothelioma.
Murrone A; Cantini L; Pecci F; Cognigni V; Copparoni C; Rinaldi S; Fiordoliva I; Monaco F; Rubini C; Barbisan F; Cimadamore A; Giampieri R; Bianchi F; Tomasetti M; Amati M; Santarelli L; Berardi R
J Thorac Dis; 2021 Oct; 13(10):5741-5751. PubMed ID: 34795923
[TBL] [Abstract][Full Text] [Related]
25. Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Malignant Peritoneal Mesothelioma.
Blackham AU; Levine EA
European J Clin Med Oncol; 2012 Jul; 4(2):25-32. PubMed ID: 24039630
[TBL] [Abstract][Full Text] [Related]
26. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Bertulli R; Hutanu I; Deraco M
Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335
[TBL] [Abstract][Full Text] [Related]
27. [Prognosis related clinical and molecular factors in malignant pleural mesothelioma].
Wang YY; Zhang H; Bai H; Wang SH; Wu MN; An TT; Zhao J; Zhuo ML; Duan JC; Wang ZJ; Wang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):162-8. PubMed ID: 23856136
[TBL] [Abstract][Full Text] [Related]
28. Cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy in patients with malignant pleural mesothelioma or pleural metastases of thymoma.
de Bree E; van Ruth S; Baas P; Rutgers EJ; van Zandwijk N; Witkamp AJ; Zoetmulder FA
Chest; 2002 Feb; 121(2):480-7. PubMed ID: 11834661
[TBL] [Abstract][Full Text] [Related]
29. Management options for malignant pleural mesothelioma: clinical and cost considerations.
Goudar RK
Drugs; 2007; 67(8):1149-65. PubMed ID: 17521217
[TBL] [Abstract][Full Text] [Related]
30. Unusual features of malignant pleural mesothelioma metastatic to the mediastinal lymph nodes.
Wagner D; Bourne PA; Yang Q; Goldman BI; Lewis JS; Xu H
Appl Immunohistochem Mol Morphol; 2008 May; 16(3):301-7. PubMed ID: 18301236
[TBL] [Abstract][Full Text] [Related]
31. E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.
Ikuta K; Yano S; Trung VT; Hanibuchi M; Goto H; Li Q; Wang W; Yamada T; Ogino H; Kakiuchi S; Uehara H; Sekido Y; Uenaka T; Nishioka Y; Sone S
Clin Cancer Res; 2009 Dec; 15(23):7229-37. PubMed ID: 19934291
[TBL] [Abstract][Full Text] [Related]
32. Molecular markers and new diagnostic methods to differentiate malignant from benign mesothelial pleural proliferations: a literature review.
Bruno R; Alì G; Fontanini G
J Thorac Dis; 2018 Jan; 10(Suppl 2):S342-S352. PubMed ID: 29507804
[TBL] [Abstract][Full Text] [Related]
33. Malignant Peritoneal Mesothelioma Mimicking Recurrent Diverticulitis.
Robalino Gonzaga ES; Guzman Rojas P; Vanar V
Cureus; 2019 Jan; 11(1):e3906. PubMed ID: 30915265
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of serum vascular endothelial growth factor in malignant pleural mesothelioma.
Yasumitsu A; Tabata C; Tabata R; Hirayama N; Murakami A; Yamada S; Terada T; Iida S; Tamura K; Fukuoka K; Kuribayashi K; Nakano T
J Thorac Oncol; 2010 Apr; 5(4):479-83. PubMed ID: 20357617
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy treatment in malignant pleural mesothelioma: a difficult history.
Cinausero M; Rihawi K; Sperandi F; Melotti B; Ardizzoni A
J Thorac Dis; 2018 Jan; 10(Suppl 2):S304-S310. PubMed ID: 29507800
[TBL] [Abstract][Full Text] [Related]
36. Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed.
Cortes-Dericks L; Carboni GL; Schmid RA; Karoubi G
Int J Oncol; 2010 Aug; 37(2):437-44. PubMed ID: 20596671
[TBL] [Abstract][Full Text] [Related]
37. The pathological and molecular diagnosis of malignant pleural mesothelioma: a literature review.
Alì G; Bruno R; Fontanini G
J Thorac Dis; 2018 Jan; 10(Suppl 2):S276-S284. PubMed ID: 29507796
[TBL] [Abstract][Full Text] [Related]
38. Malignant peritoneal mesothelioma.
Bani-Hani KE; Gharaibeh KA
J Surg Oncol; 2005 Jul; 91(1):17-25. PubMed ID: 15999348
[TBL] [Abstract][Full Text] [Related]
39. Malignant pleural mesothelioma: current concepts in treatment.
Tsiouris A; Walesby RK
Nat Clin Pract Oncol; 2007 Jun; 4(6):344-52. PubMed ID: 17534390
[TBL] [Abstract][Full Text] [Related]
40. Diffuse malignant peritoneal mesothelioma--an update on treatment.
Mirarabshahii P; Pillai K; Chua TC; Pourgholami MH; Morris DL
Cancer Treat Rev; 2012 Oct; 38(6):605-12. PubMed ID: 22104079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
